{
  "disease_name": "Endometrial cancer",
  "synonyms": [
    "Uterine cancer",
    "Womb cancer"
  ],
  "summary": "Endometrial cancer is the most common type of uterine cancer, originating in the endometrium (lining of the uterus). It is characterized by abnormal cell growth that can invade or spread, often presenting with abnormal vaginal bleeding, particularly after menopause. While the exact cause is unknown, genetic abnormalities and factors altering hormone balance are significant contributors to its development.",
  "causes": [
    "Abnormal growth of endometrial cells",
    "Genetic abnormalities",
    "Mutations in tumor suppressor genes (e.g., p53, PTEN, SPOP)",
    "Loss of PTEN function leading to PI3k/Akt/mTOR pathway up-regulation",
    "Overexpression of mutant p53",
    "Chromosomal instability",
    "Mutations in mismatch repair genes (e.g., MLH1, MLH2, MSH2, MSH6, PMS2)",
    "KRAS gene mutations",
    "Epigenetic silencing of genes",
    "PIK3CA mutations",
    "Microsatellite instability",
    "Endometrial hyperplasia"
  ],
  "risk_factors": [
    "Obesity",
    "Metabolic syndrome",
    "Excessive estrogen exposure",
    "Estrogen-only hormone replacement therapy (HRT) after menopause",
    "Type 2 diabetes",
    "Insulin resistance",
    "Starting menstruation at an early age",
    "Menopause at a later age",
    "Never having been pregnant (nulliparity)",
    "Taking tamoxifen",
    "Polycystic ovary syndrome (PCOS)",
    "Family history of endometrial cancer",
    "Lynch syndrome",
    "Endometrial hyperplasia",
    "Past radiation therapy to the pelvis",
    "Increasing age",
    "High blood pressure",
    "Previously having ovarian cancer",
    "Ovarian granulosa cell tumors",
    "Thecomas",
    "Low immune function",
    "Sitting regularly for prolonged periods",
    "Higher circulating testosterone levels in women",
    "Cowden syndrome"
  ],
  "symptoms": [
    "Abnormal vaginal bleeding",
    "Vaginal spotting in postmenopausal women",
    "Abnormal menstrual cycles (before menopause)",
    "Extremely long, heavy, or frequent bleeding episodes (before menopause)",
    "Pelvic pain",
    "Pelvic pressure",
    "Unusual vaginal discharge (thin white or clear in postmenopausal women)",
    "Enlarged uterus",
    "Pelvic mass",
    "Frequent urination",
    "Trouble urinating",
    "Pain during sexual intercourse (dyspareunia)",
    "Lower abdominal pain",
    "Pelvic cramping",
    "Uterus filled with pus (pyometrea)"
  ],
  "diagnosis": [
    "Medical history and family health history review",
    "Pelvic exam",
    "Endometrial biopsy",
    "Dilation and curettage (D&C)",
    "Histological examination of tissue",
    "Transvaginal ultrasound",
    "CT scan",
    "MRI",
    "Hysteroscopy (with biopsy)",
    "Chest x-ray",
    "Liver function tests",
    "Kidney function tests",
    "CA-125 tumor marker test",
    "PET/CT scanning (for suspected recurrence)"
  ],
  "treatments": [
    "Hysterectomy",
    "Bilateral salpingo-oophorectomy (removal of ovaries and fallopian tubes)",
    "Lymphadenectomy (removal of pelvic and para-aortic lymph nodes)",
    "Cytoreductive surgery",
    "Hormone therapy",
    "Progestins",
    "Tamoxifen (for endometrial stromal sarcomas)",
    "Hydroxyprogesterone caproate",
    "Letrozole",
    "Megestrol acetate",
    "Medroxyprogesterone",
    "Radiation therapy",
    "Vaginal brachytherapy (VBT)",
    "External beam radiotherapy (EBRT)",
    "Chemotherapy",
    "Paclitaxel",
    "Docetaxel",
    "Doxorubicin",
    "Cisplatin",
    "Carboplatin",
    "Capecitabine",
    "Gemcitabine",
    "Targeted therapy (e.g., Dostarlimab)",
    "Pelvic exenteration (for radiation-treated recurrence)",
    "Palliative care"
  ],
  "related_genes": [
    "MLH1",
    "MLH2",
    "MSH2",
    "MSH6",
    "PMS2",
    "p53",
    "PTEN",
    "Her2/neu",
    "CTNNB1 (beta-catenin)",
    "PIK3CA",
    "KRAS",
    "FGFR2",
    "SPOP",
    "ARID1A",
    "p27",
    "BRCA1",
    "BRCA2"
  ],
  "subtypes": [
    "Endometrioid carcinoma",
    "Villoglandular endometrioid adenocarcinoma",
    "Secretory endometrioid adenocarcinoma",
    "Ciliated cell endometrioid adenocarcinoma",
    "Squamous differentiation endometrioid adenocarcinoma",
    "Mucinous foci endometrioid adenocarcinoma",
    "Serous carcinoma",
    "Clear cell carcinoma",
    "Mucinous carcinoma",
    "Mixed carcinoma",
    "Undifferentiated carcinoma",
    "Malignant mixed MÃ¼llerian tumor",
    "Non-metastatic squamous cell carcinoma",
    "Transitional cell carcinoma",
    "Endometrial stromal sarcoma (ESS)",
    "Low-grade endometrial stromal sarcoma",
    "High-grade undifferentiated endometrial sarcoma (HGUS)",
    "Type I endometrial carcinoma",
    "Type II endometrial carcinoma"
  ]
}